These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Gene replacement therapy for inborn errors of purine metabolism. Nelson DL; Chang SM; Henkel-Tigges J; Wager-Smith K; Belmont JW; Caskey CT Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1065-71. PubMed ID: 3555977 [TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells. Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454 [No Abstract] [Full Text] [Related]
18. Correlations between purine levels, clinical and immunological status in ADA deficiency. Simmonds HA; Fairbanks LD; Morris GS; Hugh-Jones K; Morgan G; Levinsky RJ Adv Exp Med Biol; 1986; 195 Pt A():93-9. PubMed ID: 3728190 [No Abstract] [Full Text] [Related]
19. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Blackburn MR; Kellems RE Adv Immunol; 2005; 86():1-41. PubMed ID: 15705418 [TBL] [Abstract][Full Text] [Related]
20. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Willems L; Reichelt ME; Molina JG; Sun CX; Chunn JL; Ashton KJ; Schnermann J; Blackburn MR; Headrick JP Cardiovasc Res; 2006 Jul; 71(1):79-87. PubMed ID: 16626672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]